Amgen
NasdaqGS:AMGN Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 154 Fair Values set on narratives written by author
WA
Consensus Narrative from 26 Analysts
Breakthrough Therapies Like MariTide Will Target Broader Markets In The Future
Key Takeaways Diverse pipeline and oncology breakthroughs position Amgen for long-term revenue growth by targeting broad markets and innovative treatments. Geographic expansion and efficient operations enhance margins and support earnings and shareholder returns through strategic capital management.
View narrativeUS$316.66
FV
5.9% undervalued intrinsic discount3.03%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
26users have followed this narrative
23 days ago author updated this narrative